Anti-adhesion dressing for hemorrhoid wounds
By designing a directional expansion mechanism and layered support sheets, the problem of uncontrollable expansion direction of existing anti-adhesion dressings for hemorrhoid wounds is solved, achieving wound stability and uniform distribution of medication, thus improving the recovery effect and safety of hemorrhoid wounds.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- WUHAN XINJIAHAO MEDICAL INSTR CO LTD
- Filing Date
- 2025-06-23
- Publication Date
- 2026-07-10
AI Technical Summary
Existing anti-adhesion dressings for hemorrhoid wounds expand uncontrollably after absorbing medication, easily pushing open the anal margin, causing secondary trauma and adhesions, and affecting the recovery effect.
A directional expansion mechanism is adopted, including an elastic directional skeleton and an expansion plate, to control the vertical expansion of the drug solution. Combined with a layered support plate and an anti-permeability mechanism, the expansion direction is ensured to be vertical. A drug reservoir and a liquid absorption component are set up to achieve directional introduction and sustained release of the drug solution.
It effectively prevents dressing displacement, keeps wounds closed, reduces the risk of dressing detachment, improves stability and anti-adhesion effects, ensures uniform distribution of medication, and enhances treatment efficacy and safety.
Smart Images
Figure CN224474517U_ABST
Abstract
Description
Technical Field
[0001] This utility model relates to the field of medical dressing technology, and in particular to an anti-adhesion dressing for hemorrhoid wounds. Background Technology
[0002] Hemorrhoid wound anti-adhesion dressing is a medical dressing used for wound protection after anorectal surgery. Its main function is to cover the wound at the anus after surgery, absorb exudate, prevent tissue adhesion, and provide a moist and supportive environment for wound healing. It is suitable for local wound repair after excision of internal hemorrhoids, external hemorrhoids, and mixed hemorrhoids.
[0003] The anal area has a complex structure, and the postoperative wound is deep and easily affected by tension, friction and excrement. The wound surface is very prone to forming poor adhesions. Using anti-adhesion dressings can effectively isolate the wound edge tissues, reduce the incidence of postoperative complications, reduce the patient's pain and postoperative recovery burden, and is an important auxiliary means to improve surgical efficacy and shorten the recovery period.
[0004] Ordinary anti-adhesion dressings have problems with unstable fixation and uncontrollable deformation in postoperative applications. The special location of the wound makes it difficult for the dressing to adhere firmly. After absorbing liquid, the expansion can easily cause lateral pressure, affecting wound closure and inducing the risk of dislodgement. In the existing technology, biodegradable sponge dressings are used to absorb postoperative exudate and maintain a moist environment in the wound. At the same time, a supporting skeleton structure is added to improve the support and improve stability. However, in actual use, the direction of expansion of the dressing after absorbing water is still uncontrollable, making it difficult to keep it in the center of the wound. It may push open the anal margin, causing secondary trauma or tissue re-adhesion, affecting the recovery effect. Utility Model Content
[0005] To overcome the above shortcomings, this utility model provides an anti-adhesion dressing for hemorrhoid wounds, which aims to improve the problems in the prior art where the expansion direction of the dressing after absorbing the medicine is uncontrollable, it is difficult to keep it in the center of the wound, and it is easy to push open the anal margin, resulting in secondary trauma and adhesion.
[0006] To achieve the above objectives, the present invention adopts the following technical solution: a hemorrhoid wound anti-adhesion dressing, comprising a base sheet, a fixing mechanism provided on the outer top of the base sheet, a drug storage mechanism provided on the top of the base sheet, the drug storage mechanism being used to store and release antibacterial and hemostatic drugs, a directional expansion mechanism provided on the top of the drug storage mechanism, the directional expansion mechanism being used to control vertical expansion after absorbing the drug storage solution, an anti-permeability mechanism provided on the outer side of the directional expansion mechanism, a layered support sheet provided on the top of the directional expansion mechanism, a contact mechanism provided on the top of the layered support sheet, and a cap opening mechanism provided on the top of the contact mechanism;
[0007] The directional expansion mechanism includes an elastic directional skeleton, the top of which is fixedly connected to the bottom of the layered support sheet. Multiple connecting buckles are fixedly connected to the front and rear sides of the elastic directional skeleton. Connecting adhesive is fixedly connected to the left and right sides of the top of the elastic directional skeleton. An expansion sheet is fixedly connected to the inner side of the elastic directional skeleton. Multiple unidirectional expansion holes are opened on the top of the expansion sheet.
[0008] As a further description of the above technical solution:
[0009] The drug mechanism includes a drug reservoir, the bottom of which is fixedly connected to the top of the substrate. A drug tank is formed inside the drug reservoir. A sealing sheet is fixedly connected to the top of the drug reservoir, and a sealing strip is fixedly connected to the outside of the sealing sheet. A liquid absorption assembly is provided at the bottom of the drug tank.
[0010] As a further description of the above technical solution:
[0011] The liquid absorption assembly includes a liquid absorption through hole, the bottom of which is fixedly connected to the bottom of the inner side of the liquid tank, and multiple liquid absorption sponge columns are fixedly connected inside the liquid storage layer.
[0012] As a further description of the above technical solution:
[0013] The contact mechanism includes an adhesive surface, the bottom of which is fixedly connected to the top of the layered support sheet, and adhesive patches are fixedly connected to the left and right sides of the top of the adhesive surface. A breathable mesh is fixedly connected to the top of the adhesive surface.
[0014] As a further description of the above technical solution:
[0015] The opening mechanism includes an opening piece, the bottom of which is fixedly connected to the top of the adhesive surface. The bottom left and right sides of the opening piece are provided with openings, and adhesive components are provided on the left and right sides of the opening piece.
[0016] As a further description of the above technical solution:
[0017] Both adhesive components include an adhesive surface, and the two adhesive surfaces are fixedly connected to the left and right sides of the cover plate, respectively. The bottom of both adhesive surfaces is fixedly connected with a degradable adhesive.
[0018] As a further description of the above technical solution:
[0019] The anti-permeability mechanism includes an isolation ring, the bottom of which is fixedly connected to the top of the sealing sheet, and a degradable gel edge is fixedly connected to the outside of the isolation ring.
[0020] As a further description of the above technical solution:
[0021] The fixing mechanism includes multiple adhesive pieces, the bottoms of which are respectively fixedly connected to the top outer side of the base plate, and the tops of each of the multiple adhesive pieces are fixedly connected to an adhesive piece two.
[0022] This utility model has the following beneficial effects:
[0023] 1. In this utility model, the expansion control is achieved by the expansion limiting mechanism, so that the expansion process after liquid absorption only unfolds in the vertical direction. This effectively avoids the situation where traditional dressings cause lateral pressure and open the anal margin after absorbing water, improves the stability of the dressing in the anal wound, can maintain the wound closure state after surgery, prevents dislodgement and secondary trauma caused by positional displacement, solves the problem of uncontrollable expansion direction in the prior art, and improves the fit and anti-adhesion effect of the postoperative dressing.
[0024] 2. In this utility model, a drug reservoir and a liquid absorption component with distinct upper and lower layers are set up to realize the directional introduction and slow-release supply of drug liquid inside the dressing. This makes the expansion structure absorb liquid more evenly and the drug effect more concentrated, ensuring the continuous release of antibacterial and hemostatic components at the wound site, and improving the therapeutic effect and safety of the dressing during the postoperative recovery process. Attached Figure Description
[0025] Figure 1 This is a three-dimensional view of the anti-adhesion dressing for hemorrhoid wounds proposed in this utility model;
[0026] Figure 2 This is an exploded view of the drug mechanism in the anti-adhesion dressing for hemorrhoid wounds proposed in this utility model;
[0027] Figure 3 This is an exploded view of the directional expansion mechanism in the anti-adhesion dressing for hemorrhoid wounds proposed in this utility model;
[0028] Figure 4 This is a schematic diagram of the contact mechanism in the anti-adhesion dressing for hemorrhoid wounds proposed in this utility model;
[0029] Figure 5 This is a schematic diagram of the opening mechanism in the anti-adhesion dressing for hemorrhoid wounds proposed in this utility model.
[0030] Legend:
[0031] 1. Film; 2. Layered support sheet; 3. Directional expansion mechanism; 301. Elastic directional skeleton; 302. Connecting buckle; 303. Connecting colloid; 304. Expansion sheet; 305. One-way expansion hole; 4. Drug mechanism; 401. Drug reservoir; 402. Drug tank; 403. Sealing sheet; 404. Sealing strip; 405. Liquid absorption assembly; 4051. Liquid absorption through hole; 4052. Liquid absorption sponge column; 5. Contact mechanism; 501. Adhesive surface; 502. Breathable mesh; 503. Adhesive sheet one; 6. Opening mechanism; 601. Opening sheet; 602. Opening port; 603. Adhesive assembly; 6031. Adhesive surface; 6032. Degradable colloid; 7. Anti-permeability mechanism; 701. Isolation ring; 702. Degradable gel edge; 8. Fixing mechanism; 801. Adhesive sheet; 802. Adhesive sheet two. Detailed Implementation
[0032] The technical solutions of the present utility model will be clearly and completely described below with reference to the accompanying drawings. Obviously, the described embodiments are only some embodiments of the present utility model, and not all embodiments. Based on the embodiments of the present utility model, all other embodiments obtained by those of ordinary skill in the art without creative effort are within the protection scope of the present utility model.
[0033] Reference Figure 1 , Figure 2 and Figure 3 An embodiment of this utility model provides a hemorrhoid wound anti-adhesion dressing, including a base sheet 1, a fixing mechanism 8 provided on the outer top of the base sheet 1, a drug storage mechanism 4 provided on the top of the base sheet 1, the drug storage mechanism 4 is used to store drug solution and release antibacterial and hemostatic drugs, a directional expansion mechanism 3 is provided on the top of the drug storage mechanism 4, the directional expansion mechanism 3 is used to control vertical expansion after absorbing drug solution, an anti-permeability mechanism 7 is provided on the outer side of the directional expansion mechanism 3, a layered support sheet 2 is provided on the top of the directional expansion mechanism 3, a contact mechanism 5 is provided on the top of the layered support sheet 2, and a cap opening mechanism 6 is provided on the top of the contact mechanism 5.
[0034] The directional expansion mechanism 3 includes an elastic directional skeleton 301. The top of the elastic directional skeleton 301 is fixedly connected to the bottom of the layered support sheet 2 to connect the support structure and the expansion body to form an integrated support. Multiple connecting buckles 302 are fixedly connected to the front and rear sides of the elastic directional skeleton 301 to enhance the connection stability of the skeleton structure. Connecting adhesive 303 is fixedly connected to the top left and right sides of the elastic directional skeleton 301 to improve the fit and flexibility of the skeleton in the tissue. An expansion sheet 304 is fixedly connected to the inner side of the elastic directional skeleton 301 to support the main structure of liquid absorption and expansion. Multiple one-way expansion holes 305 are opened on the top of the expansion sheet 304 to control the drug release path and realize one-way controllable expansion.
[0035] Specifically, a fixing mechanism 8 is provided on the top outer side of the film 1 to achieve adhesion and fixation between the dressing and the skin. A drug storage mechanism 4 is provided on the top of the film 1. The drug storage mechanism 4 is used to store the drug solution and release antibacterial and hemostatic drugs to continuously provide drug action to the wound site. A directional expansion mechanism 3 is provided on the top of the drug storage mechanism 4. The directional expansion mechanism 3 is used to control the vertical expansion after absorbing the drug solution to reduce the risk of lateral pressure. An anti-permeability mechanism 7 is provided on the outer side of the directional expansion mechanism 3 to prevent external liquid from entering the drug area and control the drug outflow path. A layered support sheet 2 is provided on the top of the directional expansion mechanism 3 to provide a support base for the upper contact structure. A contact mechanism 5 is provided on the top of the layered support sheet 2 to directly contact the wound surface to achieve an adhesion effect. A capping mechanism 6 is provided on the top of the contact mechanism 5 to close before the dressing is applied and to facilitate opening during use.
[0036] The directional expansion mechanism 3 includes an elastic directional skeleton 301. The top of the elastic directional skeleton 301 is fixedly connected to the bottom of the layered support sheet 2 to connect the support structure and the expansion body to form an integrated support. Multiple connecting buckles 302 are fixedly connected to the front and rear sides of the elastic directional skeleton 301 to enhance the connection stability of the skeleton structure. Connecting adhesive 303 is fixedly connected to the top left and right sides of the elastic directional skeleton 301 to improve the conformity and flexibility of the skeleton in the tissue. An expansion sheet 304 is fixedly connected to the inner side of the elastic directional skeleton 301 to support the main structure of the liquid absorption expansion. Multiple one-way expansion holes 305 are opened on the top of the expansion sheet 304 to control the release path of the liquid and realize one-way controllable expansion to ensure accurate expansion direction and reduce lateral pressure on the wound.
[0037] Reference Figure 2 and Figure 3 The drug mechanism 4 includes a drug reservoir 401. The bottom of the drug reservoir 401 is fixedly connected to the top of the substrate 1 to form a drug storage cavity for subsequent controlled release. A drug tank 402 is provided inside the drug reservoir 401 to hold liquid drugs and keep them sealed. A sealing sheet 403 is fixedly connected to the top of the drug reservoir 401 to isolate it from the outside air and prevent drug contamination. A sealing strip 404 is fixedly connected to the outside of the sealing sheet 403 to enhance the sealing effect at the top and prevent drug evaporation. A liquid suction component 405 is provided at the bottom of the drug tank 402 to guide the drug downward for use by the expansion mechanism.
[0038] Specifically, the drug mechanism 4 includes a drug reservoir 401. The bottom of the drug reservoir 401 is fixedly connected to the top of the substrate 1 to form a drug storage cavity for subsequent controlled release. A drug tank 402 is provided inside the drug reservoir 401 to hold liquid drugs and keep them sealed. A sealing sheet 403 is fixedly connected to the top of the drug reservoir 401 to isolate it from the outside air and prevent drug contamination. A sealing strip 404 is fixedly connected to the outside of the sealing sheet 403 to enhance the sealing effect at the top and prevent drug evaporation. A liquid suction component 405 is provided at the bottom of the drug tank 402 to guide the drug downward for use by the expansion mechanism, so as to ensure that the drug is continuously and stably delivered to the expansion structure.
[0039] Reference Figure 2 , Figure 4 and Figure 5 The liquid absorption assembly 405 includes a liquid absorption through hole 4051. The bottom of the liquid absorption through hole 4051 is fixedly connected to the inner bottom of the liquid tank 402, providing a liquid channel connecting the liquid storage area and the liquid absorption structure. Multiple liquid absorption sponge columns 4052 are fixedly connected inside the liquid storage layer 401, used for storing liquid and conducting the liquid to the expansion sheet 304 after absorption. The contact mechanism 5 includes an adhesive surface 501. The bottom of the adhesive surface 501 is fixedly connected to the top of the layered support sheet 2, used to achieve adhesion to the wound surface. The top left and right sides of the adhesive surface 501 are fixedly connected to... There is an adhesive patch 503 to enhance contact stability and prevent positional displacement. The top of the adhesive surface 501 is fixedly connected to a breathable mesh 502 to maintain a local breathable environment in the wound and promote recovery. The opening mechanism 6 includes an opening piece 601. The bottom of the opening piece 601 is fixedly connected to the top of the adhesive surface 501 to form an initial closed structure for easy unsealing. The bottom left and right sides of the opening piece 601 are provided with openings 602 to open the dressing and expose the contact surface. The left and right sides of the opening piece 601 are provided with adhesive components 603 to assist in fixation and closure.
[0040] Specifically, the liquid absorption assembly 405 includes a liquid absorption through-hole 4051. The bottom of the liquid absorption through-hole 4051 is fixedly connected to the inner bottom of the liquid tank 402, providing a liquid channel connecting the liquid storage area and the liquid absorption structure. Multiple liquid absorption sponge columns 4052 are fixedly connected inside the liquid storage layer 401 for storing liquid and, after absorption, conducting the liquid to the expansion sheet 304 to achieve efficient absorption and conduction of the liquid. The contact mechanism 5 includes an adhesive surface 501. The bottom of the adhesive surface 501 is fixedly connected to the top of the layered support sheet 2 for adhesion to the wound surface. Adhesive sheets 503 are fixedly connected to the left and right sides of the top of the adhesive surface 501 for... To enhance contact stability and prevent positional displacement, a breathable mesh 502 is fixedly connected to the top of the adhesive surface 501 to maintain a breathable environment in the wound and promote recovery, thereby avoiding the risk of infection caused by heat and moisture in the wound. The opening mechanism 6 includes an opening piece 601, the bottom of which is fixedly connected to the top of the adhesive surface 501 to form an initial closed structure for easy unsealing. Opening openings 602 are provided on both the left and right sides of the bottom of the opening piece 601 to open the dressing and expose the contact surface. Adhesive components 603 are provided on both the left and right sides of the opening piece 601 to assist in fixing and closing, ensuring that the dressing remains sterile before use and is easy to handle.
[0041] Reference Figure 1 , Figure 2 and Figure 5 Both adhesive patch components 603 include an adhesive surface 6031. The two adjacent adhesive surfaces 6031 are fixedly connected to the left and right sides of the opening cover 601 to stably adhere the opening cover 601. The bottom of each adhesive surface 6031 is fixedly connected to a degradable gel 6032 for automatic softening and degradation after surgery for easy painless removal. The anti-permeability mechanism 7 includes an isolation ring 701. The bottom of the isolation ring 701 is fixedly connected to the top of the sealing sheet 403 to form an external annular sealing area. The outer side of the isolation ring 701 is fixedly connected to a degradable gel edge 702 for further adhering to the skin edge to achieve a slow-release isolation effect. The fixation mechanism 8 includes multiple adhesive pieces 801. The bottoms of the multiple adhesive pieces 801 are fixedly connected to the top outer side of the base sheet 1 to serve as an external support for the entire dressing. The top of each of the multiple adhesive pieces 801 is fixedly connected to an adhesive piece 802 to achieve adhesion and fixation between the dressing and the skin to prevent displacement.
[0042] Specifically, both adhesive patch components 603 include an adhesive surface 6031. The two adjacent adhesive surfaces 6031 are fixedly connected to the left and right sides of the opening flap 601 to stably adhere the opening flap 601. A degradable adhesive 6032 is fixedly connected to the bottom of each adhesive surface 6031 for automatic softening and degradation after surgery, facilitating painless removal and reducing secondary damage to the wound during dressing changes. The anti-permeability mechanism 7 includes an isolation ring 701. The bottom of the isolation ring 701 is fixedly connected to the top of the sealing sheet 403 to form an external annular sealing area, isolating... A degradable gel edge 702 is fixedly connected to the outer side of the ring 701 to further conform to the skin edge and achieve a slow-release isolation effect, so as to prevent external contaminants from entering and control the release path of the drug solution. The fixing mechanism 8 includes multiple adhesive patches 801. The bottoms of the multiple adhesive patches 801 are fixedly connected to the top outer side of the base film 1 to serve as an external support for the dressing. The tops of the multiple adhesive patches 801 are all fixedly connected to adhesive patches 802 to achieve the adhesion and fixation of the dressing to the skin and prevent displacement, so as to ensure that the dressing maintains a stable adhesion state during perianal activities.
[0043] Working principle: In use, first open the opening plate 601 of the opening mechanism 6 to expose the adhesive surface 501 of the contact mechanism 5 through the opening 602, completing the preparation work before dressing use. Then, invert the entire dressing so that the drug mechanism 4 faces upward. At this time, the antibacterial and hemostatic drug solution stored in the drug solution tank 402 of the drug solution storage layer 401 in the drug mechanism 4 is fully absorbed by the absorbent sponge column 4052 through the absorbent guide hole 4051 of the absorbent component 405 under the action of gravity and conducted to the expansion plate 304 of the directional expansion mechanism 3. After the expansion plate 304 absorbs the drug solution, it achieves unidirectional controllable expansion in the vertical direction through the unidirectional expansion hole 305 at the top. The elastic directional skeleton 301, the connecting buckle 302 and the connecting adhesive 303 work together to maintain the stability and flexibility of the expansion process and avoid the expansion from generating lateral pressure on the wound. The adhesive surface 501 of the contact mechanism 5 is precisely applied to the hemorrhoid wound. The first adhesive patch 503 further enhances the contact stability. The breathable mesh 502 ensures a breathable environment in the wound area, providing good conditions for wound healing. The dressing is then firmly fixed to the perianal skin by the adhesive patch 801 and the second adhesive patch 802 of the fixing mechanism 8, ensuring that the dressing will not shift during use. The isolation ring 701 and the degradable gel edge 702 of the anti-permeability mechanism 7 play a role in preventing external liquids from entering and strictly controlling the release of medication along the set path. The adhesive surface 6031 of the adhesive patch assembly 603 stably adheres to the opening patch 601. After the operation, the degradable gel 6032 automatically softens and degrades, making it easy to remove the dressing painlessly. This completes the functions of the dressing in preventing adhesion and protecting the hemorrhoid wound, continuously supplying medication, maintaining the wound environment, and facilitating easy removal.
[0044] Finally, it should be noted that the above description is only a preferred embodiment of the present utility model and is not intended to limit the present utility model. Although the present utility model has been described in detail with reference to the foregoing embodiments, those skilled in the art can still modify the technical solutions described in the foregoing embodiments or make equivalent substitutions for some of the technical features. Any modifications, equivalent substitutions, improvements, etc., made within the spirit and principles of the present utility model should be included within the protection scope of the present utility model.
Claims
1. A hemorrhoid wound anti-adhesion dressing, comprising a substrate (1), characterized in that: A fixing mechanism (8) is provided on the top outer side of the substrate (1), a drug mechanism (4) is provided on the top of the substrate (1), the drug mechanism (4) is used to store the drug solution and release antibacterial and hemostatic drugs, a directional expansion mechanism (3) is provided on the top of the drug mechanism (4), the directional expansion mechanism (3) is used to control the vertical expansion after absorbing the drug solution, an anti-permeability mechanism (7) is provided on the outer side of the directional expansion mechanism (3), a layered support sheet (2) is provided on the top of the directional expansion mechanism (3), a contact mechanism (5) is provided on the top of the layered support sheet (2), and a cap opening mechanism (6) is provided on the top of the contact mechanism (5). The directional expansion mechanism (3) includes an elastic directional skeleton (301), the top of which is fixedly connected to the bottom of the layered support plate (2). Multiple connecting buckles (302) are fixedly connected to the front and rear sides of the elastic directional skeleton (301). Connecting adhesive (303) is fixedly connected to the left and right sides of the top of the elastic directional skeleton (301). An expansion plate (304) is fixedly connected to the inner side of the elastic directional skeleton (301). Multiple unidirectional expansion holes (305) are opened on the top of the expansion plate (304).
2. The anti-adhesion dressing for hemorrhoid wounds according to claim 1, characterized in that: The drug mechanism (4) includes a drug reservoir (401), the bottom of which is fixedly connected to the top of the substrate (1). A drug tank (402) is provided inside the drug reservoir (401). A sealing sheet (403) is fixedly connected to the top of the drug reservoir (401). A sealing strip (404) is fixedly connected to the outside of the sealing sheet (403). A liquid suction assembly (405) is provided at the bottom of the inside of the drug tank (402).
3. The anti-adhesion dressing for hemorrhoid wounds according to claim 2, characterized in that: The liquid absorption assembly (405) includes a liquid absorption through hole (4051), the bottom of which is fixedly connected to the bottom of the liquid tank (402), and multiple liquid absorption sponge columns (4052) are fixedly connected inside the liquid storage layer (401).
4. The anti-adhesion dressing for hemorrhoid wounds according to claim 1, characterized in that: The contact mechanism (5) includes an adhesive surface (501), the bottom of which is fixedly connected to the top of the layered support sheet (2), and adhesive sheets (503) are fixedly connected to the left and right sides of the top of the adhesive surface (501). A breathable mesh (502) is fixedly connected to the top of the adhesive surface (501).
5. The anti-adhesion dressing for hemorrhoid wounds according to claim 4, characterized in that: The opening mechanism (6) includes an opening piece (601), the bottom of which is fixedly connected to the top of the adhesive surface (501). The opening piece (601) has openings (602) on both the left and right sides of its bottom, and adhesive components (603) are provided on both the left and right sides of the opening piece (601).
6. The anti-adhesion dressing for hemorrhoid wounds according to claim 5, characterized in that: Both adhesive components (603) include an adhesive surface (6031), and the two adhesive surfaces (6031) are fixedly connected to the left and right sides of the cover plate (601) respectively. The bottom of each adhesive surface (6031) is fixedly connected to a degradable colloid (6032).
7. The anti-adhesion dressing for hemorrhoid wounds according to claim 2, characterized in that: The anti-permeability mechanism (7) includes an isolation ring (701), the bottom of which is fixedly connected to the top of the sealing sheet (403), and a degradable gel edge (702) is fixedly connected to the outside of the isolation ring (701).
8. The anti-adhesion dressing for hemorrhoid wounds according to claim 1, characterized in that: The fixing mechanism (8) includes multiple adhesive pieces (801), the bottoms of the multiple adhesive pieces (801) are respectively fixedly connected to the top outer side of the base plate (1), and the tops of the multiple adhesive pieces (801) are all fixedly connected to adhesive pieces (802).